University of Maryland School of Pharmacy

What University of Maryland School of Pharmacy does

The University of Maryland School of Pharmacy is a public academic institution within the University System of Maryland, founded in 1841 as the fourth pharmacy school established in the United States. Headquartered at 20 North Pine Street in Baltimore with a satellite location at the Shady Grove Campus in Rockville, it serves more than 850 students across PharmD, PhD, and MS programs and is ranked 20th among 140+ U.S. pharmacy schools by U.S. News & World Report. The school is led by Dean Sarah Michel (appointed 2023) and operates through two departments — Pharmaceutical Sciences and Practice, Sciences, and Health Outcomes Research — supported by specialized research centers including the Computer-Aided Drug Design Center, Peter Lamy Center on Drug Therapy and Aging, Mass Spectrometry Center, Bio- and Nano-technology Center, Center for Translational Medicine, and Center for Research on Complex Generics, as well as the Maryland Poison Center public service.

The institution generates revenue across four primary streams: tuition and fees, grants and contracts (more than $38.5 million in FY2022 from government, industry, private, and foundation sources), continuing education for practicing pharmacists, and industry partnerships including workforce development with CVS Health. Its research portfolio includes the dual HIF-1/2 inhibitor program developed in collaboration with Johns Hopkins University, computer-aided drug design, high-throughput screening, NMR, and mass spectrometry capabilities, plus real-world evidence work via Komodo Health. Recent strategic moves include the 2025 launch of an MS in Artificial Intelligence for Drug Development led by Professor Joga Gobburu, a nine-year international partnership with Siam University announced in 2026, and a UMB MPower seed-grant collaboration worth $3 million.

Customer segments span prospective PharmD students, graduate research students, medical cannabis professionals, regulatory science students, and pharmaceutical industry professionals, served through both on-campus programs and online/hybrid graduate offerings. The school's GTM motion is direct-to-consumer via its website, information sessions, and an active digital presence across blogs (InsideSOP), social media, video content, and Capsule magazine. Distribution includes the Baltimore and Shady Grove campuses, online programs, global rotations, and experiential learning partnerships with regional healthcare facilities. The school is structurally insulated from commercial competition by its public-university and ACPE-accredited status, but is exposed to federal funding volatility, as evidenced by NIH grant cuts that prompted layoffs in the PATIENTS Program.

Name

University of Maryland School of Pharmacy

Legal name

University of Maryland School of Pharmacy

Website

https://pharmacy.umaryland.edu

Company type

Private

Founded year

1841

Operating status

Operating

Headcount range

51–100 employees

Short description

The University of Maryland School of Pharmacy is a public academic institution founded in 1841, offering PharmD, PhD, and MS programs to 850+ students. It conducts pharmaceutical research through multiple specialized centers and partners with Johns Hopkins, CVS Health, and Siam University on drug development and workforce training.

Ownership category

akta.pro rank

Product category

Pharmacy Education

NAICS

Colleges, Universities, and Professional Schools (6113)

akta.pro primary industry

Schools of Pharmacy (EDAHAGAE)

akta.pro secondary industries

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Healthcare & Clinical Professional Certifications (EDAAANAI)

Keywords

• Pharmacy education
• Pharmaceutical sciences
• Pharmacometrics training
• Regulatory science
• Clinical pharmacy

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Tuition and Fees: Revenue from student tuition and fees for PharmD, MS, PhD programs, and graduate certificates.
2. Grants and Contracts: Research funding from government, industry, private, and foundation sources. The School received more than $38.5 million in grants and contracts during fiscal year 2022.
3. Continuing Education: Professional development and CE programs for practicing pharmacists.
4. Industry Partnerships: Collaborative programs and partnerships with pharmaceutical industry for workforce development and research.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

The University of Maryland School of Pharmacy is a public professional school that delivers the Doctor of Pharmacy (PharmD) professional degree, MS and PhD graduate programs in pharmaceutical sciences, and specialized graduate degrees including an MS in Pharmacometrics, MS in Regulatory Science, and MS in Palliative Care. It also conducts translational and clinical pharmaceutical research and provides continuing professional education for pharmacists.

Product overview

The University of Maryland School of Pharmacy is an academic institution offering a comprehensive portfolio of educational programs and research services. Its academic offerings include doctoral programs (PharmD, PhD in Pharmaceutical Sciences, PhD in Pharmaceutical Health Services Research), multiple MS programs (in AI for Drug Development, Medical Cannabis Science and Therapeutics, Regulatory Science, Pharmacometrics, Palliative Care, Pharmaceutical Sciences, and Pharmaceutical Health Services Research), and graduate certificates. Research is conducted through specialized centers including the Computer-Aided Drug Design Center, Peter Lamy Center on Drug Therapy and Aging, and Center for Research on Complex Generics. The school also operates the Maryland Poison Center as a public service and provides continuing education for practicing pharmacists. The institution was founded in 1841 (fourth school of pharmacy in the U.S.) and ranks 20th among 140+ pharmacy schools nationally.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• First-in-class dual HIF inhibitors developed with Johns Hopkins completely eliminated breast, colorectal, melanoma, and prostate tumors in over 50% of treated mice
• +1 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Siam UniversitycoreStrategic or Co-development Partner · 23 June 2026Nine-year international partnership dedicated to advancing pharmacy education and experiential learning. Siam University leadership visited UMSOP to showcase the strength of this ongoing collaboration.
• Johns Hopkins UniversitycoreStrategic or Co-development Partner · 2 April 2026Collaborative research with Johns Hopkins University developing first-in-class dual HIF-1/2 inhibitors. Researchers from both institutions demonstrated combination therapy with immunotherapy completely eliminated multiple tumor types in over 50% of treated mice.
• CVS HealthcoreStrategic or Co-development PartnerUniversity of Maryland and CVS Health partnership to boost pharmacy workforce development.
• Mt. Lebanon Baptist ChurchminorStrategic or Co-development PartnerCommunity partnership focused on health equity and outreach initiatives in the Baltimore community.
• UMB MPower PartnershipcoreStrategic or Co-development PartnerCollaboration between University of Maryland, Baltimore and University of Maryland, College Park. Announced $3 million in seed grants for collaborative research.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Purdue University College of Pharmacy: Major pharmacy school with strong pharmaceutical sciences and industrial pharmacy programs, including specialized MS offerings similar to UMSOP's regulatory science and pharmacometrics tracks.
• University of Illinois at Chicago College of Pharmacy: Top-ranked public pharmacy school with significant research portfolio and urban medical campus, comparable to UMSOP in mission and operating model.
• University of Minnesota College of Pharmacy: Public university pharmacy school with research strengths in drug design, pharmacometrics, and translational sciences—directly comparable research capabilities to UMSOP's Computer-Aided Drug Design Center.
• University of Michigan College of Pharmacy: Major U.S. pharmacy school with extensive research enterprise and graduate programs in pharmaceutical sciences and health services research, comparable to UMSOP in scale and breadth.
• University of Florida College of Pharmacy: Large public pharmacy school with distributed campuses and significant research output, competing with UMSOP for graduate students and federal research funding.
• University of Pittsburgh School of Pharmacy: Top-10 U.S. pharmacy school with comparable PharmD and graduate programs, including pharmaceutical sciences and health services research, in close geographic proximity to UMSOP.
• Ohio State University College of Pharmacy: Public university pharmacy school offering PharmD, MS, and PhD programs with substantial research funding, competing with UMSOP for students and faculty in the mid-Atlantic and Midwest.
• University of Kentucky College of Pharmacy: Public pharmacy school with comparable PharmD, MS, and PhD offerings and active research centers, particularly in pharmaceutical sciences and policy research.
• University of North Carolina Eshelman School of Pharmacy: Top-ranked U.S. pharmacy school offering PharmD, PhD, and MS programs with strong research portfolio. Most direct comparable to UMSOP given similar program mix, graduate research depth, and pharmaceutical sciences focus.
• University of California San Francisco School of Pharmacy: Leading U.S. pharmacy school with strong pharmaceutical sciences and translational research programs, comparable to UMSOP in graduate program scope and research intensity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/umsop
• YouTubeyoutube.com/umbschoolofpharmacy
• Facebookfacebook.com/UMSOP
• LinkedInlinkedin.com/company/university-of-maryland-school-of-pharmacy
• Instagraminstagram.com/umsop

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Maryland School of Pharmacy